Skip to main content
. 2013 Jul 22;16(3):282–294. doi: 10.1111/hpb.12128

Table 2.

Blood product utilization during and 24 h after liver transplantation (LT) in hepatitis C virus (HCV)-infected recipients

Blood product Group 1, non-transfused (n = 65) Group 2, transfused (n = 192) P-value
Whole blood, units, median (range) 0 1 (0–4) 0.04
PRBC during LT, units, median (range) 0 3 (0–102) <0.001
PRBC within 24 h of LT, units, median (range) 0 2 (0–28) <0.001
FFP during LT, units, median (range) 0 5 (0–70) <0.001
FFP within 24 h of LT, units, median (range) 0 1 (0–21) 0.008
Cryoprecipitate during LT, units, median (range) 0 1 (0–10) <0.001
Cryoprecipitate within 24 h of LT, units, median (range) 0 1 (0–2) 0.037
Platelets during LT, units, median (range) 0 1 (0–12) 0.001
Platelets within 24 h of LT, units, median (range) 0 1 (0–5) 0.002

PRBC, packed red blood cells; FFP, fresh frozen plasma.